Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nick Dand

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Nature Communications|December 17, 2021
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, et al.
Nature Communications|August 7, 2021
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, et al.
The British Journal of Dermatology|May 24, 2022
Biomarkers of systemic treatment response in people with psoriasis: a scoping reviewMark Corbett, Ravi Ramessur, David Marshall, et al.
JAMA Dermatology|September 19, 2019
Association of Serum Ustekinumab Levels With Clinical Response in PsoriasisTeresa Tsakok, Nina Wilson, Nick Dand, et al.
The British Journal of Dermatology|April 28, 2022
Biomarkers of disease progression in people with psoriasis: a scoping reviewRavi Ramessur, Mark Corbett, David Marshall, et al.
Nature Communications|December 14, 2018
Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acneChristos Petridis, Alexander A Navarini, Nick Dand, et al.
Annals of the Rheumatic Diseases|August 20, 2017
Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasisJohn Bowes, James Ashcroft, Nick Dand, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Multi-cytokine based TWAS for seven inflammatory skin disorders identify candidate causal genes in keratinocytesHaihan Zhang, Matthew T Patrick, Mrinal K Sarkar, et al.
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Nature Communications|December 17, 2021
Author Correction: Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, et al.
Nature Communications|August 7, 2021
Enhanced NF-κB signaling in type-2 dendritic cells at baseline predicts non-response to adalimumab in psoriasisRosa Andres-Ejarque, Hira Bahadur Ale, Katarzyna Grys, et al.
The British Journal of Dermatology|May 24, 2022
Biomarkers of systemic treatment response in people with psoriasis: a scoping reviewMark Corbett, Ravi Ramessur, David Marshall, et al.
JAMA Dermatology|September 19, 2019
Association of Serum Ustekinumab Levels With Clinical Response in PsoriasisTeresa Tsakok, Nina Wilson, Nick Dand, et al.
The British Journal of Dermatology|April 28, 2022
Biomarkers of disease progression in people with psoriasis: a scoping reviewRavi Ramessur, Mark Corbett, David Marshall, et al.
Nature Communications|December 14, 2018
Genome-wide meta-analysis implicates mediators of hair follicle development and morphogenesis in risk for severe acneChristos Petridis, Alexander A Navarini, Nick Dand, et al.
Annals of the Rheumatic Diseases|August 20, 2017
Cross-phenotype association mapping of the MHC identifies genetic variants that differentiate psoriatic arthritis from psoriasisJohn Bowes, James Ashcroft, Nick Dand, et al.
Clinical and Translational Science|April 30, 2026
Evaluation of a Therapeutic Drug Monitoring Strategy for Adalimumab in Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Ruoheng Wei, et al.
The Journal of Allergy and Clinical Immunology|May 27, 2026
Multi-cytokine based TWAS for seven inflammatory skin disorders identify candidate causal genes in keratinocytesHaihan Zhang, Matthew T Patrick, Mrinal K Sarkar, et al.
Clinical and Translational Science|January 30, 2020
Using Real-World Data to Guide Ustekinumab Dosing Strategies for Psoriasis: A Prospective Pharmacokinetic-Pharmacodynamic StudyShan Pan, Teresa Tsakok, Nick Dand, et al.
Pageof 7